Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3075 | 2072 | 36.6 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
409 | 2 | ADENOSINE//ADENOSINE RECEPTORS//ATP | 16639 |
3075 | 1 | MOL RECOGNIT SECT//ADENOSINE RECEPTORS//ADENOSINE RECEPTOR ANTAGONISTS | 2072 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOL RECOGNIT SECT | address | 618472 | 6% | 35% | 120 |
2 | ADENOSINE RECEPTORS | authKW | 606016 | 12% | 17% | 239 |
3 | ADENOSINE RECEPTOR ANTAGONISTS | authKW | 249884 | 2% | 40% | 42 |
4 | MOL MODELING SECT | address | 158841 | 1% | 37% | 29 |
5 | ADENOSINE A3 RECEPTOR | authKW | 149352 | 2% | 32% | 32 |
6 | LIGAND RECEPTOR MODELING STUDIES | authKW | 133956 | 0% | 91% | 10 |
7 | A1 ADENOSINE RECEPTOR | authKW | 132314 | 2% | 28% | 32 |
8 | ADENOSINE A1 RECEPTOR | authKW | 121009 | 3% | 14% | 60 |
9 | TRICYCLIC HETEROAROMATIC SYSTEMS | authKW | 117883 | 0% | 100% | 8 |
10 | A2B ANTAGONISTS | authKW | 103148 | 0% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 20429 | 30% | 0% | 613 |
2 | Pharmacology & Pharmacy | 10071 | 41% | 0% | 854 |
3 | Chemistry, Organic | 934 | 11% | 0% | 229 |
4 | Biochemistry & Molecular Biology | 745 | 20% | 0% | 406 |
5 | Physiology | 283 | 5% | 0% | 104 |
6 | Peripheral Vascular Diseases | 98 | 3% | 0% | 58 |
7 | Cardiac & Cardiovascular System | 87 | 4% | 0% | 81 |
8 | Biophysics | 78 | 3% | 0% | 70 |
9 | Neurosciences | 65 | 6% | 0% | 125 |
10 | Computer Science, Interdisciplinary Applications | 17 | 1% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL RECOGNIT SECT | 618472 | 6% | 35% | 120 |
2 | MOL MODELING SECT | 158841 | 1% | 37% | 29 |
3 | SEZ FARMACOL | 93757 | 2% | 16% | 41 |
4 | LBC | 71352 | 1% | 19% | 25 |
5 | DIPARTIMENTO SCI FARMACEUT | 59319 | 6% | 3% | 128 |
6 | PHARMACEUT POPPELSDORF | 51567 | 0% | 50% | 7 |
7 | INTERNAL MED MOL PHYSIOL BIOL PHYS | 47152 | 0% | 80% | 4 |
8 | DRUG PHARMACOL SCI | 47144 | 0% | 40% | 8 |
9 | SEZ FARMACEUT NUTRACEUT | 47144 | 0% | 40% | 8 |
10 | DIPARTIMENTO MED CLIN SPERIMENTALE SEZ FARMACOL | 44206 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF MEDICINAL CHEMISTRY | 37218 | 11% | 1% | 233 |
2 | DRUG DEVELOPMENT RESEARCH | 17337 | 3% | 2% | 59 |
3 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 9832 | 3% | 1% | 56 |
4 | PURINERGIC SIGNALLING | 9757 | 1% | 4% | 17 |
5 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 9271 | 3% | 1% | 62 |
6 | BRITISH JOURNAL OF PHARMACOLOGY | 8700 | 5% | 1% | 103 |
7 | MOLECULAR PHARMACOLOGY | 8400 | 4% | 1% | 75 |
8 | BIOORGANIC & MEDICINAL CHEMISTRY | 7339 | 4% | 1% | 81 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4150 | 4% | 0% | 78 |
10 | EUROPEAN JOURNAL OF PHARMACOLOGY | 3585 | 4% | 0% | 84 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE RECEPTORS | 606016 | 12% | 17% | 239 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
2 | ADENOSINE RECEPTOR ANTAGONISTS | 249884 | 2% | 40% | 42 | Search ADENOSINE+RECEPTOR+ANTAGONISTS | Search ADENOSINE+RECEPTOR+ANTAGONISTS |
3 | ADENOSINE A3 RECEPTOR | 149352 | 2% | 32% | 32 | Search ADENOSINE+A3+RECEPTOR | Search ADENOSINE+A3+RECEPTOR |
4 | LIGAND RECEPTOR MODELING STUDIES | 133956 | 0% | 91% | 10 | Search LIGAND+RECEPTOR+MODELING+STUDIES | Search LIGAND+RECEPTOR+MODELING+STUDIES |
5 | A1 ADENOSINE RECEPTOR | 132314 | 2% | 28% | 32 | Search A1+ADENOSINE+RECEPTOR | Search A1+ADENOSINE+RECEPTOR |
6 | ADENOSINE A1 RECEPTOR | 121009 | 3% | 14% | 60 | Search ADENOSINE+A1+RECEPTOR | Search ADENOSINE+A1+RECEPTOR |
7 | TRICYCLIC HETEROAROMATIC SYSTEMS | 117883 | 0% | 100% | 8 | Search TRICYCLIC+HETEROAROMATIC+SYSTEMS | Search TRICYCLIC+HETEROAROMATIC+SYSTEMS |
8 | A2B ANTAGONISTS | 103148 | 0% | 100% | 7 | Search A2B+ANTAGONISTS | Search A2B+ANTAGONISTS |
9 | A2B ADENOSINE RECEPTOR | 102273 | 1% | 37% | 19 | Search A2B+ADENOSINE+RECEPTOR | Search A2B+ADENOSINE+RECEPTOR |
10 | XANTHINES | 81311 | 1% | 20% | 28 | Search XANTHINES | Search XANTHINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CRISTALLI, G , LAMBERTUCCI, C , MARUCCI, G , VOLPINI, R , DAL BEN, D , (2008) A(2A) ADENOSINE RECEPTOR AND ITS MODULATORS: OVERVIEW ON A DRUGGABLE GPCR AND ON STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS AND BINDING REQUIREMENTS OF AGONISTS AND ANTAGONISTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 15. P. 1525-1552 | 153 | 60% | 42 |
2 | FREDHOLM, BB , IJZERMAN, AP , JACOBSON, KA , KLOTZ, KN , LINDEN, J , (2001) INTERNATIONAL UNION OF PHARMACOLOGY. XXV. NOMENCLATURE AND CLASSIFICATION OF ADENOSINE RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 4. P. 527 -552 | 121 | 37% | 1625 |
3 | MORO, S , GAO, ZG , JACOBSON, KA , SPALLUTO, G , (2006) PROGRESS IN THE PURSUIT OF THERAPEUTIC ADENOSINE RECEPTOR ANTAGONISTS.MEDICINAL RESEARCH REVIEWS. VOL. 26. ISSUE 2. P. 131-159 | 104 | 76% | 107 |
4 | CRISTALLI, G , CACCIARI, B , DAL BEN, D , LAMBERTUCCI, C , MORO, S , SPALLUTO, G , VOLPINI, R , (2007) HIGHLIGHTS ON THE DEVELOPMENT OF A(2A) ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS.CHEMMEDCHEM. VOL. 2. ISSUE 3. P. 260 -281 | 125 | 71% | 0 |
5 | TALIANI, S , PUGLIESI, I , BELLANDI, M , LA MOTTA, C , DA SETTIMO, F , (2010) A(3) RECEPTOR LIGANDS: PAST, PRESENT AND FUTURE TRENDS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 10. P. 942-975 | 89 | 85% | 10 |
6 | DAL BEN, D , LAMBERTUCCI, C , MARUCCI, G , VOLPINI, R , CRISTALLI, G , (2010) ADENOSINE RECEPTOR MODELING: WHAT DOES THE A(2A) CRYSTAL STRUCTURE TELL US?.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 10. P. 993-1018 | 106 | 67% | 21 |
7 | CHEONG, SL , FEDERICO, S , VENKATESAN, G , MANDEL, AL , SHAO, YM , MORO, S , SPALLUTO, G , PASTORIN, G , (2013) THE A3 ADENOSINE RECEPTOR AS MULTIFACETED THERAPEUTIC TARGET: PHARMACOLOGY, MEDICINAL CHEMISTRY, AND IN SILICO APPROACHES.MEDICINAL RESEARCH REVIEWS. VOL. 33. ISSUE 2. P. 235-335 | 143 | 44% | 15 |
8 | MULLER, CE , JACOBSON, KA , (2011) RECENT DEVELOPMENTS IN ADENOSINE RECEPTOR LIGANDS AND THEIR POTENTIAL AS NOVEL DRUGS.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1808. ISSUE 5. P. 1290 -1308 | 88 | 53% | 117 |
9 | POULSEN, SA , QUINN, RJ , (1998) ADENOSINE RECEPTORS: NEW OPPORTUNITIES FOR FUTURE DRUGS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 6. ISSUE 6. P. 619 -641 | 99 | 67% | 248 |
10 | GONZALEZ, MP , TERAN, C , TEIJEIRA, M , (2008) SEARCH FOR NEW ANTAGONIST LIGANDS FOR ADENOSINE RECEPTORS FROM QSAR POINT OF VIEW. HOW CLOSE ARE WE?.MEDICINAL RESEARCH REVIEWS. VOL. 28. ISSUE 3. P. 329-371 | 104 | 59% | 11 |
Classes with closest relation at Level 1 |